Industry News
A bright future for brain research
A new report provides commitment to national investment in brain research. [ + ]
Industry's first catalogue of in vitro human tissue assays
Contract research organisation Biopta has launched the first catalogue of assays based on human functional tissues. The catalogue serves to provide the scientific community with ready access to assays that improve the prediction of safety, absorption and efficacy of drug candidates in humans. [ + ]
Program to reintroduce disease-free devils
San Diego Zoo Global and the University of Sydney are collaborating to save the Tasmanian devil. The institutions are working on the reintroduction and management of a population free of devil facial tumour disease. [ + ]
Benitec to raise up to $31.5m in placement
Benitec Biopharma (ASX:BLT) has launched a private placement to raise up to $31.5 million to further its ddRNAi development programs. [ + ]
AusBiotech members recognised in Healthcare Awards
Admedus, Nanosonics, Universal Biosensors and CSL were among the companies recognised last week as Australia's best performers in the Australian healthcare industry at the 2014 Frost & Sullivan Australia Healthcare Awards. [ + ]
Call for an Australian Brain initiative and bionic brain
Health Minister Peter Dutton today launched the 'Inspiring smarter brain research in Australia' report at Parliament House, Canberra. The report contains recommendations from a High Flyers Think Tank hosted by the Australian Academy of Science in Melbourne last year. [ + ]
Funding for seven CRCs announced
Minister for Industry Ian Macfarlane has announced almost $186 million in funding as part of the 16th CRC (Cooperative Research Centre) Program selection round. The government funding will create three new CRCs and extend four existing CRCs. [ + ]
MS researchers win Thermo Scientific Cellome Award
Thermo Fisher Scientific has presented its 2014 Cellome Award to the authors of the article 'A regenerative approach to the treatment of multiple sclerosis', featured in the October 2013 issue of Nature. [ + ]
Prima signs first licence deal for CVac
Prima Biomed (ASX:PRR) has finalised a licensing agreement with Israel's Neopharm covering CVac, Prima's treatment candidate under development for ovarian cancer. [ + ]
CTx gets largest share of CRC funding round
The government has allocated $186m for the 16th round of the CRC program, and the Cancer Therapeutics CRC is the top beneficiary. [ + ]
Alchemia names new CEO, narrows 1H14 loss
Alchemia (ASX:ACL) has selected COO Thomas Liquard to replace Charles Walker as CEO and announced a slimmer 1H14 net loss of $5.5m. [ + ]
Prizes for stem cell research
Two new $50,000 prizes for stem cell researchers. [ + ]
Garlic neutralises resistant bacteria
A researcher at the University of Copenhagen has written his PhD thesis on the positive properties of garlic, with particular emphasis on its effect against bacteria. [ + ]
Giant Magellan Telescope passes design and construction reviews
The Giant Magellan Telescope (GMT) project has passed two major expert reviews over its design and construction. This clears the way for the project to proceed towards construction approval. [ + ]
Successful phase 2 results in Huntington disease trial
Prana Biotechnology has announced the results of its phase 2 clinical trial investigating the drug PBT2 as a treatment for Huntington disease. [ + ]
